Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$61.7M Buy
2,893,720
+50,000
+2% +$987K 0.01% 1539
2026
Q1
$43.1M Sell
2,843,720
-2,400
-0.1% -$41.7K 0.01% 1800
2025
Q4
$57.1M Buy
2,846,120
+22,400
+0.8% +$475K 0.01% 1480
2025
Q3
$68.3M Sell
2,823,720
-8,000
-0.3% -$212K 0.01% 1338
2025
Q2
$75M Buy
2,831,720
+8,000
+0.3% +$208K 0.01% 1180
2025
Q1
$76.7M Hold
2,823,720
0.01% 1107
2024
Q4
$115M Hold
2,823,720
0.02% 833
2024
Q3
$81.1M Hold
2,823,720
0.02% 849
2024
Q2
$125M Hold
2,823,720
0.03% 538
2024
Q1
$175M Buy
+2,823,720
New +$196M 0.04% 408
2020
Q3
Sell
-37,200
Closed -$4.12M 8118
2020
Q2
$4.12M Buy
+37,200
New +$3.62M ﹤0.01% 2197
2020
Q1
Sell
-24,300
Closed -$1.59M 8081
2019
Q4
$1.59M Buy
+24,300
New +$1.49M ﹤0.01% 3771

Other funds holding FIVN

UBS Group's FIVN Position: Q2 2026 in Review

UBS Group reduced its FIVE9 (FIVN) stake by 24% in Q2 2026, selling an estimated $4.12M and leaving 676,362 shares worth $14.4M. The position accounts for ﹤0.01% of the portfolio, ranked #3032.

UBS Group first reported a position in FIVN in Q4 2014 and has held it in 46 quarters since. The position peaked at $67.3M in Q4 2024. 293 funds tracked by Wall St. Rank hold FIVN as of Q2 2026.

  • UBS Group held 676,362 shares of FIVE9 worth $14.4M as of Q2 2026.
  • UBS Group sold 208,532 FIVE9 shares in Q2 2026, an estimated $4.12M.
  • FIVE9 made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #3032 holding.
  • UBS Group first reported a position in FIVE9 in Q4 2014 and has held it in 46 quarters since.
  • UBS Group's FIVE9 position peaked at $67.3M in Q4 2024.
  • 293 funds tracked by Wall St. Rank held FIVE9 as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.